FDA Finalizes First Guidance for Psychedelic Clinical Trials
NORTH AMERICA – Yesterday was a major milestone for anyone keeping tabs on psychedelic medicine and drug policy. The FDA officially published its finalized guidance, “Psychedelic Drugs: Considerations for Clinical Investigations,” in the Federal Register.